Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)
  4. Fast Track Articles
  5. Fast Track Article
image of Significance of Serum Magnesium in Parathyroid Hormone Level in Patients with Chronic Kidney Disease
file format pdf download PDF

Abstract

Introduction

In chronic kidney disease (CKD) patients, elevated parathyroid hormone (PTH) is linked to cardiovascular mortality and morbidity. Levels of PTH are influenced by serum phosphate (P) and calcium (Ca), but little is known about the impact of magnesium (Mg) on PTH. Hence, this study investigated the relationship between PTH and Mg in peritoneal dialysis (PD) patients and non-dialysis patients from three hospitals in China.

Material and methods

This cross-sectional study included 446 chronic kidney disease stage 5 (CKD5) patients from three hospitals in southern China. PTH was naturally transformed to Ln_PTH for analysis. The chi-square test, Pearson correlation analysis, hierarchical regression analysis, and t-test were used to explore the relationships between Ln_PTH and gender, diabetes history, Mg, P, Ca, albumin (Alb), red blood cells (RBC), hemoglobin (Hb), white blood cells (WBC), and platelet (Plt).

Results

Patients with diabetes mellitus (DM) had lower levels of Ln_PTH in PD (<0.05) and non-dialysis (>0.05) patients. Ln_PTH levels were negatively associated with Mg and Ca but positively associated with and Alb in PD patients (all <0.05). Ln_PTH levels were negatively associated with age but positively associated with in non-dialysis patients (all <0.05).

Conclusion

This study demonstrates the negative effect of Mg and diabetes on Ln_PTH levels in CKD5 patients.

© 2025 The Author(s). Published by Bentham Science Publishers
© 2025 The Author(s). Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode.
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303311081241022042321
2025-01-08
2025-05-22

  • From This Site

    /content/journals/emiddt/10.2174/0118715303311081241022042321
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. Wang W.H. Chen L.W. Lee C.C. Sun C.Y. Shyu Y.C. Hsu H.R. Chien R.N. Wu I.W. Association between parathyroid hormone, 25 (OH) vitamin D, and chronic kidney disease: A population-based study. BioMed Res. Int. 2017 2017 1 9 10.1155/2017/7435657 28367447
    [Google Scholar]
  2. Nikodimopoulou M. Liakos S. Secondary hyperparathyroidism and target organs in chronic kidney disease. Hippokratia 2011 15 Suppl. 1 33 38 21897756
    [Google Scholar]
  3. Melamed M.L. Eustace J.A. Plantinga L. Jaar B.G. Fink N.E. Coresh J. Klag M.J. Powe N.R. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int. 2006 70 2 351 357 10.1038/sj.ki.5001542 16738536
    [Google Scholar]
  4. Geng S. Kuang Z. Peissig P.L. Page D. Maursetter L. Hansen K.E. Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease. Osteoporos. Int. 2019 30 10 2019 2025 10.1007/s00198‑019‑05033‑3 31190122
    [Google Scholar]
  5. Levin A. Bakris G.L. Molitch M. Smulders M. Tian J. Williams L.A. Andress D.L. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int. 2007 71 1 31 38 10.1038/sj.ki.5002009 17091124
    [Google Scholar]
  6. Omije D. Norris K. Wang J. Pan D. Kermah D. Gupta A. Race is a major determinant of secondary hyperparathyroidism in uremic patients: Comparative study of Blacks and Hispanics. Clin. Nephrol. 2008 70 10 312 318 10.5414/CNP70312 18826856
    [Google Scholar]
  7. Vincenti F. Arnaud S.B. Recker R. Genant H. Amend W.J.C. Feduska N.J. Salvatierra O. Parathyroid and bone response of the diabetic patient to uremia. Kidney Int. 1984 25 4 677 682 10.1038/ki.1984.73 6482171
    [Google Scholar]
  8. Vavanikunnel J. Sewing L. Triantafyllidou M. Steighardt A. Baumann S. Egger A. Grize L. Felix B. Kraenzlin M. Henzen C. Meier C. Determinants of low bone turnover in type 2 diabetes-the role of PTH. Calcif. Tissue Int. 2022 111 6 587 596 10.1007/s00223‑022‑01022‑7 36190530
    [Google Scholar]
  9. Brown E.M. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol. Rev. 1991 71 2 371 411 10.1152/physrev.1991.71.2.371 2006218
    [Google Scholar]
  10. Cho M.S. Lee K.S. Lee Y.K. Ma S.K. Ko J.H. Kim S.W. Kim N.H. Choi K.C. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Korean J. Intern. Med. (Korean. Assoc. Intern. Med.) 2002 17 2 114 121 10.3904/kjim.2002.17.2.114 12164088
    [Google Scholar]
  11. Ohya M. Negi S. Sakaguchi T. Koiwa F. Ando R. Komatsu Y. Shinoda T. Inaguma D. Joki N. Yamaka T. Ikeda M. Shigematsu T. Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients. J. Clin. Endocrinol. Metab. 2014 99 10 3873 3878 10.1210/jc.2013‑4396 24937533
    [Google Scholar]
  12. Li W. Zhang S. Risk factors of parathyroid dysfunction in elderly patients with chronic kidney disease undergoing hemodialysis. Adv. Clin. Exp. Med. 2015 24 6 1007 1012 10.17219/acem/23439 26771973
    [Google Scholar]
  13. Fang L. Tang B. Hou D. Meng M. Xiong M. Yang J. Effect of parathyroid hormone on serum magnesium levels: The neglected relationship in hemodialysis patients with secondary hyperparathyroidism. Ren. Fail. 2016 38 1 50 56 10.3109/0886022X.2015.1106847 26671274
    [Google Scholar]
  14. Shamspour N. Molahoseini M. Azmandian J. Ahmadipour H. Baniasad A. To evaluate the relationship between serum magnesium and parathyroid hormone levels in peritoneal dialysis and hemodialysis patients. Int. Urol. Nephrol. 2022 55 5 1321 1327 10.1007/s11255‑022‑03445‑5 36526918
    [Google Scholar]
  15. Levey A.S. Stevens L.A. Schmid C.H. Zhang Y.L. Castro A.F. Feldman H.I. Kusek J.W. Eggers P. Van Lente F. Greene T. Coresh J. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009 150 9 604 612 10.7326/0003‑4819‑150‑9‑200905050‑00006 19414839
    [Google Scholar]
  16. Al-Azem H. Khan A. Primary hyperparathyroidism. CMAJ 2011 183 10 E685 E689 10.1503/cmaj.090675 21540163
    [Google Scholar]
  17. Bilezikian J.P. Bandeira L. Khan A. Cusano N.E. Hyperparathyroidism. Lancet 2018 391 10116 168 178 10.1016/S0140‑6736(17)31430‑7 28923463
    [Google Scholar]
  18. Rodríguez-Ortiz M.E. Canalejo A. Herencia C. Martínez-Moreno J.M. Peralta-Ramírez A. Perez-Martinez P. Navarro-González J.F. Rodríguez M. Peter M. Gundlach K. Steppan S. Passlick-Deetjen J. Muñoz-Castañeda J.R. Almaden Y. Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration. Nephrol. Dial. Transplant. 2014 29 2 282 289 10.1093/ndt/gft400 24103811
    [Google Scholar]
  19. Cunningham J. Rodríguez M. Messa P. Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients. Clin. Kidney J. 2012 5 Suppl. 1 i39 i51 10.1093/ndtplus/sfr166 26069820
    [Google Scholar]
  20. Navarro J.F. Mora C. Jiménez A. Torres A. Macía M. García J. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am. J. Kidney Dis. 1999 34 1 43 48 10.1016/S0272‑6386(99)70106‑X 10401014
    [Google Scholar]
  21. Navarro J.F. Mora C. Macia M. Garcia J. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Perit. Dial. Int. 1999 19 5 455 461 10.1177/089686089901900509 11379859
    [Google Scholar]
  22. Pletka P. Bernstein D.S. Hampers C.L. Merrill J.P. Sherwood L.M. Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis. Metabolism 1974 23 7 619 630 10.1016/S0026‑0495(74)80021‑1 4600477
    [Google Scholar]
  23. Hulter H.N. Peterson J.C. Renal and systemic magnesium metabolism during chronic continuous PTH infusion in normal subjects. Metabolism 1984 33 7 662 666 10.1016/0026‑0495(84)90067‑2 6738367
    [Google Scholar]
  24. Sanda S. Schlingmann K.P. Newfield R.S. Autosomal dominant hypoparathyroidism with severe hypomagnesemia and hypocalcemia, successfully treated with recombinant PTH and continuous subcutaneous magnesium infusion. J. Pediatr. Endocrinol. Metab. 2008 21 4 385 391 10.1515/JPEM.2008.21.4.385 18556971
    [Google Scholar]
  25. Gerdhem P. Isaksson A. Åkesson K. Obrant K.J. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos. Int. 2005 16 12 1506 1512 10.1007/s00198‑005‑1877‑5 15824889
    [Google Scholar]
  26. Sass M.R. Wewer Albrechtsen N.J. Pedersen J. Hare K.J. Borbye-Lorenzen N. Kiss K. Vilsbøll T. Knop F.K. Poulsen S.S. Jørgensen N.R. Holst J.J. Ørskov C. Hartmann B. Secretion of parathyroid hormone may be coupled to insulin secretion in humans. Endocr. Connect. 2020 9 7 747 754 10.1530/EC‑20‑0092 32698134
    [Google Scholar]
  27. Reyes-García R. Rozas-Moreno P. López-Gallardo G. García-Martín A. Varsavsky M. Avilés-Perez M.D. Muñoz-Torres M. Serum levels of bone resorption markers are decreased in patients with type 2 diabetes. Acta Diabetol. 2013 50 1 47 52 10.1007/s00592‑011‑0347‑0 22042129
    [Google Scholar]
  28. Suzuki K. Kurose T. Takizawa M. Maruyama M. Ushikawa K. Kikuyama M. Sugimoto C. Seino Y. Nagamatsu S. Ishida H. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: The preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density. Diabetes Res. Clin. Pract. 2005 68 2 117 125 10.1016/j.diabres.2004.08.006 15860239
    [Google Scholar]
  29. Sugimoto T. Ritter C. Morrissey J. Hayes C. Slatopolsky E. Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int. 1990 37 6 1522 1527 10.1038/ki.1990.144 2194068
    [Google Scholar]
  30. Block G.A. Klassen P.S. Lazarus J.M. Ofsthun N. Lowrie E.G. Chertow G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J. Am. Soc. Nephrol. 2004 15 8 2208 2218 10.1097/01.ASN.0000133041.27682.A2 15284307
    [Google Scholar]
  31. Dobnig H. Piswanger-Sölkner J.C. Roth M. Obermayer-Pietsch B. Tiran A. Strele A. Maier E. Maritschnegg P. Sieberer C. Fahrleitner-Pammer A. Type 2 diabetes mellitus in nursing home patients: Effects on bone turnover, bone mass, and fracture risk. J. Clin. Endocrinol. Metab. 2006 91 9 3355 3363 10.1210/jc.2006‑0460 16735485
    [Google Scholar]
  32. Memon I. Norris K.C. Bomback A.S. Peralta C. Li S. Chen S.C. McCullough P.A. Whaley-Connell A. Jurkovitz C. Tamura M.K. Saab G. The association between parathyroid hormone levels and hemoglobin in diabetic and nondiabetic participants in the national kidney foundationʼs kidney early evaluation program. Cardiorenal Med. 2013 3 2 120 127 10.1159/000351229 23922552
    [Google Scholar]
  33. Tanaka M. Komaba H. Fukagawa M. Emerging association between parathyroid hormone and anemia in hemodialysis patients. Ther. Apher. Dial. 2018 22 3 242 245 10.1111/1744‑9987.12685 29767854
    [Google Scholar]
  34. Habas E. Eledrisi M. Khan F. Elzouki A.N.Y. Secondary hyperparathyroidism in chronic kidney disease: Pathophysiology and management. Cureus 2021 13 7 e16388 10.7759/cureus.16388 34408941
    [Google Scholar]
  35. Shidara K. Inaba M. Okuno S. Imanishi Y. Yamakawa T. Ishimura E. Kumeda Y. Nishizawa Y. Influence of nutritional status on serum large N-truncated PTH, but not PTH(1–84) in hemodialysis patients. Biomed. Pharmacother. 2007 61 2-3 142 147 10.1016/j.biopha.2006.08.008 17270383
    [Google Scholar]
  36. Liu L. Wang L. Wang X. Xiong M. Cao H. Jiang L. Yang J. Serum PTH associated with malnutrition determined by bioelectrical impedance technology in chronic kidney disease patients. Int. J. Endocrinol. 2022 2022 1 7 10.1155/2022/1222480 35573870
    [Google Scholar]
  37. Gutiérrez O.M. Mannstadt M. Isakova T. Rauh-Hain J.A. Tamez H. Shah A. Smith K. Lee H. Thadhani R. Jüppner H. Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N. Engl. J. Med. 2008 359 6 584 592 10.1056/NEJMoa0706130 18687639
    [Google Scholar]
/content/journals/emiddt/10.2174/0118715303311081241022042321
Loading
Significance of Serum Magnesium in Parathyroid Hormone Level in Patients with Chronic Kidney Disease
Bentham Science Publishers ; https://doi.org/10.2174/0118715303311081241022042321
/content/journals/emiddt/10.2174/0118715303311081241022042321
/content/journals/emiddt/10.2174/0118715303311081241022042321
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Chronic kidney disease ; magnesium ; diabetes ; intact parathyroid hormone ; peritoneal dialysis patients ; non-dialysis patients

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test